Difference between revisions of "Minutes - Medication WG 2021-06-08"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) |
KarlienErauw (talk | contribs) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
* Annemieke Vergauwe | * Annemieke Vergauwe | ||
* Bruno Casneuf | * Bruno Casneuf | ||
| − | |||
* Jean-Michel Polfliet | * Jean-Michel Polfliet | ||
* José Costa Teixeira | * José Costa Teixeira | ||
| Line 18: | Line 17: | ||
===== '''Excused/Not present''' ===== | ===== '''Excused/Not present''' ===== | ||
* Dieter Sauvillers | * Dieter Sauvillers | ||
| + | * Elhassan Baazizi | ||
* Hanne Vuegen | * Hanne Vuegen | ||
* Jan Lenie | * Jan Lenie | ||
| Line 34: | Line 34: | ||
===== '''Minutes''' ===== | ===== '''Minutes''' ===== | ||
| − | * FAGG has sent us through RIZIV a [https://drive.google.com/file/d/1QjyHgY77UhKN6vlpx6FEErTp4NoqKkef/view?usp=sharing mapping SAMv1 to SAMv2] | + | * Magistral |
| + | * FAGG has sent us through RIZIV a [https://drive.google.com/file/d/1QjyHgY77UhKN6vlpx6FEErTp4NoqKkef/view?usp=sharing mapping SAMv1 to SAMv2], that was sent to all WG-members last week | ||
::* please collect feedback in your team and send it by email to [http://mailto:karlien.erauw@agoria.be Karlien] | ::* please collect feedback in your team and send it by email to [http://mailto:karlien.erauw@agoria.be Karlien] | ||
* feedback on the FHIR medication workshop that took place with a couple of WG-members last week | * feedback on the FHIR medication workshop that took place with a couple of WG-members last week | ||
| Line 49: | Line 50: | ||
::::* different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength) | ::::* different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength) | ||
| − | + | * During the workshop 12 scenario's have been defined: | |
| − | * 12 scenario's have been defined | ||
::* Prescribed branded medication is changed by another branded medication from the same VOS-cluster | ::* Prescribed branded medication is changed by another branded medication from the same VOS-cluster | ||
::* Prescribed medication is changed by another medication from a different VOS-cluster | ::* Prescribed medication is changed by another medication from a different VOS-cluster | ||
| Line 58: | Line 58: | ||
::::* e.g. stomach protector that is delivered to the patient | ::::* e.g. stomach protector that is delivered to the patient | ||
::* Dispense of prescribed medication, and dispense of a product that can be done without a prescription | ::* Dispense of prescribed medication, and dispense of a product that can be done without a prescription | ||
| − | ::* Dispense of new brand medication that is given because the old is unavailable, so giving to | + | ::* Dispense of new brand medication that is given because the old is unavailable, so giving to continue the cure and not to replace it |
::* Refuse the dispense prescribed medication | ::* Refuse the dispense prescribed medication | ||
::* Dispense of medication that was prescribed, but not taken | ::* Dispense of medication that was prescribed, but not taken | ||
| Line 79: | Line 79: | ||
::::* patient is admitted, hospital takes over the medication from the scheme | ::::* patient is admitted, hospital takes over the medication from the scheme | ||
::::* patient is discharged, hospital reconciles the medication that was used with the medication scheme | ::::* patient is discharged, hospital reconciles the medication that was used with the medication scheme | ||
| + | |||
| + | * Do we have to extend the model to include individual prescriptions ? | ||
| + | ::* is the posology already sufficient as it is now in the model ? | ||
| + | ::* the regimen exists today and the model should foresee something similar | ||
| + | ::* for the pharmacist the time b/w the different intakes and with or without food is important | ||
| + | ::* José will be working on a use case for this | ||
| + | |||
| + | * Swiss approach of medication treatment plan | ||
| + | ::* doctor starts a medication treatment plan and everything afterwards is part of this plan | ||
| + | ::* Swiss documentation: | ||
| + | ::::* [https://www.e-health-suisse.ch/fileadmin/user_upload/Dokumente/E/report-emedication-architecture-epr-summary.pdf Summary] | ||
| + | ::::* [https://www.e-health-suisse.ch/fileadmin/user_upload/Dokumente/E/Implementation_Guide_eMedication_Architecture_Specs_013_Anhoerung.pdf Detailed specifications v0.13] | ||
| + | ::* In Belgium now we only have prescriptions, we don't have a starting point | ||
| + | ::* often a doctor starts with a prescription without it being part of a fixed plan (try-out) | ||
| + | ::* a medication can be part of multiple treatment plans | ||
| + | ::* this starting point (medication plan) does not seem to be mandatory, it can be optional | ||
| + | ::* Can we have a look at the Swiss documents and check what is useful for us (f.e. use cases) | ||
'''Action items for next meeting''' | '''Action items for next meeting''' | ||
| − | ::* | + | ::* José will work on a posology use case |
| + | ::* Review of Swiss documents | ||
'''Next meeting June 22 at 11AM''' | '''Next meeting June 22 at 11AM''' | ||
Latest revision as of 10:15, 8 June 2021
Attendees
- Anne Nerenhausen
- Annemieke Vergauwe
- Bruno Casneuf
- Jean-Michel Polfliet
- José Costa Teixeira
- Katrien Thorré
- Karlien Erauw
- Nick Hermans
- Pablo Christiaens
- Richard Francken
- Robin Bosman
- Thomas Van Langendonck
- Tom De Backer
- Tom Henkens
Excused/Not present
- Dieter Sauvillers
- Elhassan Baazizi
- Hanne Vuegen
- Jan Lenie
- Jean-Louis Maggetto
- Jens Penny
- Jeroen De Wilde
- Lars Vanreppelen
- Marc Buckens
- Nils Devos
- Richard Francken
- Will van Norel
Agenda
- review of SAMv1 to SAMv2 mapping
- review of the examples
Minutes
- Magistral
- FAGG has sent us through RIZIV a mapping SAMv1 to SAMv2, that was sent to all WG-members last week
- please collect feedback in your team and send it by email to Karlien
- feedback on the FHIR medication workshop that took place with a couple of WG-members last week
- “Stofnaam” aka “Substance” should be changed by VOS-cluster. Under a VOS-cluster we understand the following:
- Same substance(s)
- Same strength
- Comparable package size
- Form of administration
- Additional info:
- https://www.riziv.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/geneesmiddel-voorschrijven/Paginas/goedkoopste-geneesmiddelen.aspx
- https://www.riziv.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/geneesmiddel-voorschrijven/Paginas/voorschijven-stofnaam-regels-voorschrijver.aspx
- to check: Contramal 100 mg vs Contramal 100 mg retard
- comparable package sizes are not packaged in Belgium (was under discussion once)
- different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
- During the workshop 12 scenario's have been defined:
- Prescribed branded medication is changed by another branded medication from the same VOS-cluster
- Prescribed medication is changed by another medication from a different VOS-cluster
- Different strength, different package size or different form of administration is dispensed
- Different substance(s) is dispensed
- Dispense medication before the prescription of the general practitioner
- e.g. stomach protector that is delivered to the patient
- Dispense of prescribed medication, and dispense of a product that can be done without a prescription
- Dispense of new brand medication that is given because the old is unavailable, so giving to continue the cure and not to replace it
- Refuse the dispense prescribed medication
- Dispense of medication that was prescribed, but not taken
- e.g. an antibiotic that is prescribed when doing international travel as a safeguard
- Dispense of medication that was prescribed, but not taken till the end
- e.g. an antibiotic that is prescribed but when using the patient had an allergic reaction
- might be connected to scenario 3, when the pharmacist gives an alternative
- The recording of anesthetic, contrast and similar medications in the medication scheme
- The recording of non-medication aka pharmaceutical products
- Food supplement
- Sunscreen
- ...
- The view and/or filters for
- a GP
- a nurse / caretaker
- a pharmacist
- a specialist
- a patient
- The patient is admitted to hospital and there the medication is changed to better help the patient.
- patient is admitted, hospital takes over the medication from the scheme
- patient is discharged, hospital reconciles the medication that was used with the medication scheme
- Do we have to extend the model to include individual prescriptions ?
- is the posology already sufficient as it is now in the model ?
- the regimen exists today and the model should foresee something similar
- for the pharmacist the time b/w the different intakes and with or without food is important
- José will be working on a use case for this
- Swiss approach of medication treatment plan
- doctor starts a medication treatment plan and everything afterwards is part of this plan
- Swiss documentation:
- In Belgium now we only have prescriptions, we don't have a starting point
- often a doctor starts with a prescription without it being part of a fixed plan (try-out)
- a medication can be part of multiple treatment plans
- this starting point (medication plan) does not seem to be mandatory, it can be optional
- Can we have a look at the Swiss documents and check what is useful for us (f.e. use cases)
Action items for next meeting
- José will work on a posology use case
- Review of Swiss documents
Next meeting June 22 at 11AM
